FDA Draft Guidance: Coalition Submits Formal Comment

| No Comments | No TrackBacks
Coalition submits formal Comment on FDA Draft Guidance on "Presenting Risk Information in Prescription Drug and Medical Device Promotion": Read Comment here: CHC_CommentFDA_Aug25_09.pdf

No TrackBacks

TrackBack URL: http://64.33.81.11/cgi-bin/MTOS/mt-tb.cgi/20

Leave a comment

About this Entry

This page contains a single entry by mtadmin published on August 25, 2009 12:40 PM.

Coalition Asks Senate to Focus on Patient Access to Care was the previous entry in this blog.

Coalition/CMPI Report Shows That Doctors & Patients Benefit Greatly from Commercially Supported CME is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.